Navigation Links


CSI Specialty Group Launches Specialty Pharmacy Podcast

2/10/2016
SANFORD, Fla. , Feb. 10, 2016 CSI Specialty Group (CSI) expanded its specialty pharmacy educational offerings today with the launch of the Specialty Pharmacy Podcast. A free, weekly show, the Specialty Pharmacy Podcast is an industry-first, aimed at providing real-world education, discussion and context amongst specialty pharmacy peers and professionals. --> --> The Sp... [Comments]

Resolve Announces Positive Clinical Data From RSLV-132 Lupus Study

2/10/2016
SEATTLE , Feb. 10, 2016  Resolve Therapeutics, LLC, a clinical stage biopharmaceutical company developing potentially transformative new approaches to the treatment of lupus and Sjogrens syndrome, today announced the successful completion of a multiple ascending dose study in patients with systemic lupus erythematosus (SLE) with its lead compound RSLV-132. --> --> Da... [Comments]

Lonza and Renova Therapeutics Announce Manufacturing Agreement for Clinical Supply of RT-100 Gene Therapy

2/10/2016
BASEL, Switzerland and SAN DIEGO , Feb. 10, 2016 Lonza Houston , Inc., a global leader in viral gene therapy manufacturing, and Renova™ Therapeutics, a biopharmaceutical company developing gene therapy treatments for congestive heart failure and other chronic diseases, have entered into a Manufacturing Services Agreement to develop a scalable manufacturing process a... [Comments]

CVS Health Offering Meningitis Vaccines to Residents in Santa Clara County, CA

2/10/2016
WOONSOCKET, R.I. , Feb. 10, 2016  CVS Health (NYSE: CVS ) is offering Meningitis B vaccines to people living in Santa Clara County, CA , in response to confirmed cases of Meningitis B on the Santa Clara University campus. CVS Pharmacy stores and MinuteClinic walk-in medical clinics have vaccines available to protect patients against the disease. Students at Santa Clara... [Comments]

Urologix Announces Private Ownership

2/10/2016
MINNEAPOLIS , Feb. 10, 2016 Urologix, the market leader for in-office minimally invasive medical products for the treatment of Benign Prostatic Hyperplasia (BPH), announces new private ownership and is operating as Urologix LLC. Ash Keswani , a medical device industry veteran of more than 20 years, has been named President of the Limited Liability Company.  Plymouth,... [Comments]

Immune Pharmaceuticals Files New Patent Application for Ceplene in Combination with Checkpoint Inhibitors

2/10/2016
NEW YORK , Feb. 10, 2016 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ), "Immune", a clinical-stage biopharmaceutical company, announced today that it has filed a patent application directed to the treatment of Acute Myeloid Leukemia and other cancers. --> --> The new invention provides methods of treating cancer by administration of Ceplene (histamine dihydrochloride) in... [Comments]

Rich Pharmaceuticals, Inc. Announces Reverse Split

2/10/2016
BEVERLY HILLS, Calif. , Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC Markets: RCHA) ("Rich Pharmaceuticals" or the "Company") today announced a 1-for-100 reverse split of its issued and outstanding shares of common stock effective at the opening of trading on Thursday, February 11, 2016. The Company's common stock will trade on a split-adjusted basis under new CUSIP numb... [Comments]

Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries

2/10/2016
TOKYO , Feb. 10, 2016  Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka , "Astellas") announced today that it has successfully completed, through its indirect wholly-owned subsidiary Laurel Acquisition Inc. ("Laurel"), a tender offer to purchase all issued and outstanding shares of common stock of Ocata Therapeutics, Inc. (NASDAQ: OCAT, President and... [Comments]

Oxis Celebrates 'Clinical Trial Triumph' As Patient Passes 18 Months In Complete Cancer Remission

2/10/2016
LOS ANGELES , Feb. 10, 2016  Oxis International Inc. (OTC/QB: OXIS) announced today that the company's blood cancer drug, OXS-1550, was described as a "clinical trial triumph" after one of the first patients treated with the drug went into complete cancer remission. Daniel Vallera , a research scientist at the University of Minnesota Masonic Cancer Center. --> Daniel... [Comments]

Worldwide Clinical Trials Expert to Present at Evidence EU 2016

2/10/2016
LONDON , February 10, 2016 A Worldwide Clinical Trials expert will present at Evidence EU 2016, which will be held at Victoria Park Plaza in London , 24-25 February 2016. Worldwide will host an informative seminar on technology and future advances for late phase research on Wednesday, 24 Feb at 15:00. The seminar, led by Lorna Graham , associate director of project manag... [Comments]

[previous] [next]
(Date:2/10/2016)... ... February 10, 2016 , ... 10 Best Water is excited to ... water brand owners that topped the list as a result of their commitment to ... premier brand was Tibet 5100, a top notch water company that specializes in providing ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 ... more than 200 of the country’s top healthcare executives to share insights on ... benefit of the Forum is the provider-centric perspective, experience, expertise and strategy shared ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience ... across their network of laboratory service centers across the country. Launched in April of ... in the detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... the Ohio Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's ... Convention Center. , As the longest running and largest worker's compensation event ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... February 26th: Amateur & Professional Divisions - Time: 7:00pm – 10:00pm | ... | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , Facebook: http://www.facebook.com/uspolesportsfederation ...
Breaking Medicine News(10 mins):
... skin preparation an important ... infections. Scrub Care brand Prevail-Fx ... high efficacy and safety for ... offers the highest level of ...
These simple but effective single-dose, hands-off, ampulized applicators have revolutionized skin preparation in hospitals....
... Mixed Titer Performance Panel consists of plasma ... strong positive for antibodies to HTLV I ... use by manufacturers and diagnostic laboratories to ... from all major test systems are included ...
Comprised of a monofilament polypropylene mesh coated with hydrophilic porcine collagen, Pelvitex™ mesh is clinically proven coating to enhance the healing process, along with the strength and d...
Medicine Products:
(Date:2/10/2016)... -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), ... quarter and full year ended December 31, 2015. ... a transformational year for Vanda with the continued growth ... approval of HETLIOZ for Non-24," said Mihael H. Polymeropoulos, ... to our U.S. product portfolio builds on this success ...
(Date:2/10/2016)... --> --> This press release is intended for ... Japan .  --> A separate press release has been prepared ... Shire continues to strengthen its presence in ... continues to strengthen its presence in Japan ... continues to strengthen its presence in Japan ...
(Date:2/10/2016)... A new report from business intelligence provider GBI Research ... Alzheimer,s disease market will more than double from just under $5 billion in ... Rate (CAGR) of 11%. Canada , France ... Spain , the UK, and Japan , and ... --> Canada , France , ...
Breaking Medicine Technology: